Biofrontera (BFRIW) Restructuring Costs (2021)

Biofrontera (BFRIW) recorded quarterly Restructuring Costs of $98000.0 in Q4 2021, down 50.75% quarter-over-quarter from $199000.0 in Q3 2021.

Biofrontera (BFRIW) Restructuring Costs (2021) Analysis & Trends

Biofrontera's Restructuring Costs history runs 1 years deep, the most recent figure standing at $98000.0 for Q4 2021.

In Q4 2021, Restructuring Costs changed N/A year-over-year to $98000.0; the TTM figure through Dec 2021 stood at $764000.0 (changed N/A YoY), while the FY2021 annual figure was $752000.0, down 33.57% from the prior year.
Restructuring Costs was $98000.0 for Q4 2021 at Biofrontera, down from $199000.0 in the prior quarter.
In the past five years, Restructuring Costs ranged from a high of $281000.0 in Q1 2021 to a low of $98000.0 in Q4 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Teva Pharmaceutical Industries	38.34 Bn	34.60 Bn	1.97 Bn
2	Zoetis	33.27 Bn	31.33 Bn	1.62 Bn
3	United Therapeutics	23.75 Bn	21.60 Bn	648.10 Mn
4	Aurora Cannabis	17.11 Bn	17.03 Bn	33.43 Mn
5	Neurocrine Biosciences	16.37 Bn	15.05 Bn	800.70 Mn
6	Elanco Animal Health	11.78 Bn	11.35 Bn	785.00 Mn
7	Alkermes	7.05 Bn	6.54 Bn	-116.06 Mn
8	Lantheus Holdings	6.49 Bn	5.99 Bn	230.92 Mn
9	Hims & Hers Health	6.19 Bn	5.44 Bn	396.79 Mn
10	Biofrontera	-	-	14.09 Mn

Download Data